Clovis Oncology Inc (CLVS) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Clovis Oncology inc   (NASDAQ: CLVS)


Clovis Oncology Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Clovis Oncology Inc's ROI in the third quarter of 2022?
Clovis Oncology Inc recorded a cumulative net loss of $-252 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -183.94%.

Within the Healthcare sector 896 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 4910.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM -65.54 % -19.2 % -17.41 % -19.53 % -20.54 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -401 272 330 348 395
Return On Investment (TTM) - -78.35 % -70.27 % -69.75 % -75.25 %
CLVS's Overall Ranking # 4910 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -59.25 % -8.62 % -3.03 % -4.59 % -4.44 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -252 -263 -258 -265 -299

CLVS Company Profile >> Back to CLVS Roi Comparisons >> See Annual CLVS Return On Investment



Return On Investment CLVS's Ranking
Within: No.
Industry # 429
Sector # 897
Overall # 4910

Return On Investment Statistics
High Average Low
-20.5 %
-54.99 %
-93.47 %
(Mar 31 2014)   (Sep 30 2022)







Financial Statements
Clovis Oncology Inc's III. Quarter Investments $ -401 Millions CLVS's Balance sheet
Clovis Oncology Inc's III. Quarter Income $ -56 Millions Quarterly CLVS's Income Statement
CLVS's Income by Division See CLVS's Income by Division


CLVS Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 348 421 537 738 654
Y / Y Investment Growth -17.36 % -21.6 % -27.28 % 12.86 % 118.66 %
Net Income in Millions -265 -369 -400 -368 -346
Y / Y Net Income Growth - - - - -
Annual Return On Investment -76.1 % -87.78 % -74.63 % -49.88 % -52.99 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CLVS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CLVS's Competitors
Subscribers only: Roi for Clovis Oncology Inc's Suppliers
Subscribers only: Return On Investment for CLVS's Customers

Other Ratios
CLVS's Roa CLVS's Inventory Turnover Ratio CLVS's Growth Rates CLVS's Dividend Statistics
CLVS's Profitability Ratios CLVS's Asset Turnover Ratio CLVS's Dividend Growth
CLVS's Roe CLVS's Valuation Ratios CLVS's Financial Strength Ratios CLVS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.